- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of Ocular Side Effects of Selinexor
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-03-17
DOI
10.1002/onco.13756
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- XPO1-dependent nuclear export as a target for cancer therapy
- (2020) Nancy G. Azizian et al. Journal of Hematology & Oncology
- Selinexor: First Global Approval
- (2019) Yahiya Y. Syed DRUGS
- Carboplatin- and/or paclitaxel-induced ischemic retinopathy
- (2019) Abdelrahman M. Elhusseiny et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
- (2019) Asfar S. Azmi et al. CLINICAL CANCER RESEARCH
- Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
- (2018) Dan T. Vogl et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
- (2018) Vinod Vijay Subhash et al. Scientific Reports
- Birdshot-like Chorioretinopathy Associated With Pembrolizumab Treatment
- (2018) Luis A. Acaba-Berrocal et al. JAMA Ophthalmology
- Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
- (2018) Nizar J. Bahlis et al. BLOOD
- Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma
- (2016) Mrinal M. Gounder et al. JOURNAL OF CLINICAL ONCOLOGY
- Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient
- (2016) Takashi Arai et al. JOURNAL OF DERMATOLOGY
- Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
- (2016) Robert Nakayama et al. Oncotarget
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
- (2014) Giovanni Gravina et al. Journal of Hematology & Oncology
- Nucleo-cytoplasmic transport as a therapeutic target of cancer
- (2014) Giovanni Luca Gravina et al. Journal of Hematology & Oncology
- Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- (2014) Kaushal Parikh et al. Journal of Hematology & Oncology
- Ocular Adverse Events of Systemic Inhibitors of the Epidermal Growth Factor Receptor: Report of 5 Cases
- (2012) Alejandro Saint-Jean et al. OPHTHALMOLOGY
- Persistent Corneal Epithelial Defect Associated With Erlotinib Treatment
- (2009) Keegan S Johnson et al. CORNEA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started